Altered Cortical Glutamate Neurotransmission in Schizophrenia: Evidence from Morphological Studies of Pyramidal Neurons

Annals of the New York Academy of Sciences

Volumn 1003, Issue , 2003, Pages 102-112

  Lewis, David A ^a   Glantz, Leisa A ^b   Pierri, Joseph N ^a   Sweet, Robert A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Deep layer 3; Dorsolateral prefrontal cortex; Pyramidal neurons; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; MARKER; NEUROFILAMENT PROTEIN; NEUROLEPTIC AGENT;

ASSOCIATION CORTEX; AUDITORY NERVOUS SYSTEM; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CELL DENSITY; CELL LABELING; CELL NUCLEUS; CELL SUBPOPULATION; CELL TYPE; CELL VOLUME; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DENDRITIC CELL; DENDRITIC SPINE; ELECTROPHYSIOLOGY; HUMAN; IMMUNOREACTIVITY; NERVE CELL; NERVE CONDUCTION; NERVE FIBER; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SENSORY NERVE; SIGNAL TRANSDUCTION; THALAMOCORTICAL TRACT;

EID: 0347722470     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1300.007     Document Type: Conference Paper

References (49)

1. MIRNICS, K., F.A. MIDDLETON, A. MARQUEZ, et al. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67.
2. HARRISON, P.J. & D.A. LEWIS. 2003. Neuropathology in schizophrenia. In Schizophrenia. S. Hirsch & D.R. Weinberger, Eds.: Chapter 17: 310-325. Blackwell Science Ltd. Oxford.
3. WHITE, E.L. 1989. Cortical Circuits. Boston-Basel. Birkhauser.
4. DEFELIPE, J. 1997. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuro. 14: 1-19.
5. JONES, E.G. 1984. Laminar distribution of cortical efferent cells. In Cerebral Cortex, Vol. 1. A. Peters & E.G. Jones, Eds. 521-553. Plenum Press. New York.
6. SOLOWAY, A.S., M.L. PUCAK, D.S. MELCHITZKY & D.A. LEWIS. 2002. Dendritic morphology of callosal and ipsilateral projection neurons in monkey prefrontal cortex. Neuroscience 109: 461-471.
7. HOF, P.R., L.G. UNGERLEIDER, M.J. WEBSTER, et al. 1996. Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways. J. Comp. Neurol. 376: 112-127.
8. LEVITT, J.B., D.A. LEWIS, T. YOSHIOKA & J.S. LUND. 1993. Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 & 46). J. Comp. Neurol. 338: 360-376.
9. PUCAK, M.L., J.B. LEVITT, J.S. LUND & D.A. LEWIS. 1996. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J. Comp. Neurol. 376: 614-630.
10. MELCHITZKY, D.S., S.R. SESACK, M.L. PUCAK & D.A. LEWIS. 1998. Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex. J. Comp. Neurol. 390: 211-224.
11. MELCHITZKY, D.S., G. GONZALEZ-BURGOS, G. BARRIONUEVO & D.A. LEWIS. 2001. Synaptic targets of the intrinsic axon collaterals of supragranular pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol. 430: 209-221.
12. MELCHITZKY, D.S. & D.A. LEWIS. 2003. Preferential targeting of parvalbumin interneurons by local axon terminals of supragranular pyramidal neurons in monkey prefrontal cortex. Cereb. Cortex 13: 452-460.
13. FELLEMAN, D.J. & D.C. VAN ESSEN. 1991. Distributed hierarchical processing in the primate cerebral cortex. Cereb. Cortex 1: 1-47.
14. GIGUERE, M. & P.S. GOLDMAN-RAKIC. 1988. Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J. Comp. Neurol. 277: 195-213.
15. LEWIS, D.A. 2000. Is there a neuropathology of schizophrenia? The Neuroscientist 6: 208-218.
16. CULLEN, T.J., M.A. WALKER, N. PARKINSON, et al. 2003. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr. Res. 60: 157-166.
17. GLANTZ, L.A. & D.A. LEWIS. 2000. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57: 65-73.
18. DEFELIPE, J. & I. FARINAS. 1992. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog. Neurobiol. 39: 563-607.
19. GAREY, L.J., W.Y. ONG, T.S. PATEL, et al. 1998. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 65: 446-453.
20. GLANTZ, L.A. & D.A. LEWIS. 1997. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch. Gen. Psychiatry 54: 943-952.
21. KARSON, C.N., R.E. MRAK, K.O. SCHLUTERMAN, et al. 1999. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophenia: a possible neurochemical basis for "hypofrontality." Mol. Psychiatry 4: 39-45.
22. PERRONE-BIZZOZERO, N.I., A.C. SOWER, E.D. BIRD, et al. 1996. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc. Natl. Acad. Sci. USA 93: 14182-14187.
23. SELEMON, L.D. & P.S. GOLDMAN-RAKIC. 1999. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45: 17-25.
24. ANDERSON, S.A., J.D. CLASSEY, F. CONDÉ, et al. 1995. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67: 7-22.
25. BOURGEOIS, J.-P., P.S. GOLDMAN-RAKIC & P. RAKIC. 1994. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex 4: 78-96.
26. HUTTENLOCHER, P.R. & A.S. DABHOLKAR. 1997. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387: 167-178.
27. LEWIS, D.A. 1997. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16: 385-398.
28. MIRNICS, K., F.A. MIDDLETON, D.A. LEWIS & P. LEVITT. 2001. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24: 479-486.
29. AHMED, B., J.C. ANDERSON, R.J. DOUGLAS, et al. 1994. Polyneuronal innervation of spiny stellate neurons in cat visual cortex. J. Comp. Neurol. 341: 39-49.
30. BARBAS, H. 1992. Architecture and cortical connections of the prefrontal cortex in the Rhesus monkey. Adv. Neurol. 57: 91-115.
31. HAYES, T.L. & D.A. LEWIS. 1996. Magnopyramidal neurons in the anterior motor speech region: dendritic features and interhemispheric comparisons. Arch. Neurol. 53: 1277-1283.
32. JACOBS, B., L. DRISCOLL & M. SCHALL. 1997. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol. 386: 661-680.
33. GILBERT, C.D. & J.P. KELLY. 1975. The projections of cells in different layers of the cat's visual cortex. J. Comp. Neurol. 63: 81-106.
34. LUND, J.S., R.D. LUND, A.E. HENDRICKSON, et al. 1975. The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J. Comp. Neurol. 164: 287-304.
35. PIERRI, J.N., C.L.E. VOLK, S. AUH, et al. 2001. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex in subjects with schizophrenia. Arch. Gen. Psychiatry 58: 466-473.
36. RAJKOWSKA, G., L.D. SELEMON & P.S. GOLDMAN-RAKIC. 1998. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 55: 215-224.
37. PIERRI, J.N., C.L.E. VOLK, S. AUH, et al. 2003. Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations. Biol. Psychiatry 54: 111-120.
38. LEWIS, D.A. 2002. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 26: 143-154.
39. HOF, P.R., K. COX & J.H. MORRISON. 1990. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301: 44-54.
40. HOF, P.R. & J.H. MORRISON. 1995. Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: a quantitative immunohistochemical analysis. J. Comp. Neurol. 352: 161-186.
41. BERTOLINO, A., G. ESPOSITO, J.H. CALLICOTT, et al. 2000. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am. J. Psychiatry 157: 26-33.
42. SPENCE, S.A., P.F. LIDDLE, M.D. STEFAN, et al. 2000. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk: focal dysfunction and distributed disconnectivity reappraised. Br. J. Psychiatry 176: 52-60.
43. MCCARLEY, R.W., C.G. WIBLE, M. FRUMIN, et al. 1999. MRI anatomy of schizophrenia. Biol. Psychiatry 45: 1099-1119.
44. JAVITT, D.C., A.M. SHELLEY, G. SILIPO & J.A. LIEBERMAN. 2000. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch. Gen. Psychiatry 57: 1131-1137.
45. SWEET, R.A., J.N. PIERRI, S. AUH, et al. 2003. Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology 28: 599-609.
46. MOLINARI, M., M.E. DELL'ANNA, E. RAUSELL, et al. 1995. Auditory thalamocortical pathways defined in monkeys by calcium-binding protein immunoreactivity. J. Comp. Neurol. 362: 171-194.
47. BYNE, W., M.S. BUCHSBAUM, L.A. MATTIACE, et al. 2002. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry 159: 59-65.
48. Weinberger, D.R. 1999. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry 45: 395-402.
49. VOLK, D.W. & D.A. LEWIS. 2002. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol. Behav. 77: 501-505.